Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (231-240 of 258) with videos related to

Pageof 26
Sort By:
European Journal of Haematology|June 16, 2024
Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomesAyman Sayyed, Leeann Wilson, Vered Stavi, et al.
Haematologica|February 10, 2022
A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells <i>in vitro</i> and <i>in vivo</i>Lucas C M Arruda, Arwen Stikvoort, Melanie Lambert, et al.
Annals of Hematology|October 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survivalSergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux, et al.
Oncoimmunology|September 14, 2020
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccinationTanja Lövgren, Maria Wolodarski, Stina Wickström, et al.
Bone Marrow Transplantation|May 3, 2025
Mechanisms underlying seizures and hypothermia during busulphan administrationIbrahim El-Serafi, Sofia Berglund, Fadwa BenKessou, et al.
Bone Marrow Transplantation|February 5, 2024
Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignanciesTommy Alfaro Moya, Maria Queralt Salas, Abel Santos Carreira, et al.
Bone Marrow Transplantation|July 2, 2020
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Ora Bascom, et al.
Transplantation and Cellular Therapy|January 28, 2024
Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell TransplantationMaria Queralt Salas, Tommy Alfaro-Moya, Eshetu G Atenafu, et al.
Transplantation and Cellular Therapy|July 12, 2023
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell TransplantationAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
European Journal of Haematology|February 2, 2023
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysisRam Vasudevan Nampoothiri, Kenny Tang, Andre Schuh, et al.
Pageof 26

Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
European Journal of Haematology|June 16, 2024
Impact of cytomegalovirus (CMV) seroconversion pre-allogeneic hematopoietic cell transplantation on posttransplant outcomesAyman Sayyed, Leeann Wilson, Vered Stavi, et al.
Haematologica|February 10, 2022
A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells <i>in vitro</i> and <i>in vivo</i>Lucas C M Arruda, Arwen Stikvoort, Melanie Lambert, et al.
Annals of Hematology|October 24, 2025
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survivalSergio Rodriguez-Rodriguez, Nihar Desai, Christopher Lemieux, et al.
Oncoimmunology|September 14, 2020
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccinationTanja Lövgren, Maria Wolodarski, Stina Wickström, et al.
Bone Marrow Transplantation|May 3, 2025
Mechanisms underlying seizures and hypothermia during busulphan administrationIbrahim El-Serafi, Sofia Berglund, Fadwa BenKessou, et al.
Bone Marrow Transplantation|February 5, 2024
Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignanciesTommy Alfaro Moya, Maria Queralt Salas, Abel Santos Carreira, et al.
Bone Marrow Transplantation|July 2, 2020
Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantationMaria Queralt Salas, Eshetu G Atenafu, Ora Bascom, et al.
Transplantation and Cellular Therapy|January 28, 2024
Outcomes of Antithymocyte Globulin-Post-Transplantation Cyclophosphamide-Cyclosporine-Based versus Antithymocyte Globulin-Based Prophylaxis for 10/10 HLA-Matched Unrelated Donor Allogeneic Hematopoietic Cell TransplantationMaria Queralt Salas, Tommy Alfaro-Moya, Eshetu G Atenafu, et al.
Transplantation and Cellular Therapy|July 12, 2023
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell TransplantationAbel Santos Carreira, Maria Queralt Salas, Mats Remberger, et al.
European Journal of Haematology|February 2, 2023
Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysisRam Vasudevan Nampoothiri, Kenny Tang, Andre Schuh, et al.
Pageof 26